Craniopharyngiomas account for 2–5% of all primary brain tumors and 5–10% of pediatric brain tumors. Despite their benign ...

DENVER -- Patients who discontinued treatment for advanced kidney cancer because of immune-related adverse events (irAEs) had ...

A Yale research team has created a new imaging technique that reveals the hidden connections between aging, disease, and ...

Craniopharyngioma (CP), although histologically benign, is a surgically challenging sellar-region tumor for which stereotactic irradiation is increasingly used as an alternative or adjuvant strategy.

During a live event, Moshe C. Ornstein, MD, MA, considered the trial design and outcomes of 2 trials of combination regimens ...

PathExplore is designed to deliver a structured, standardized, and scalable panel of human interpretable features (HIFs) from H&E whole-slide images. Powered by PathAI’s next-generation foundation ...

The combination of artificial intelligence and human collaboration is transforming the analysis of tissue (anatomopathological) samples obtained from biopsies or surgical specimens. A study published ...

More than a quarter of patients with renal cell carcinoma on active surveillance experience spontaneous tumor regression, researchers report.

Prime Medicine, Inc. ( PRME) Discusses Liver Disease Franchise Strategy With Focus on Wilson Disease November 12, 2025 8:00 AM EST ...

A secondary analysis of FASCINATE-2 Phase 2 trial demonstrated denifanstat improved fibrosis, inflammation and steatosis in advanced qF4 MASH ...

Enspectra Health today announced the publication of pivotal clinical trial results in JAMA Dermatology, demonstrating that its handheld cross-modal imaging system enables physicians to accurately iden ...

Renal cell carcinoma (RCC) accounts for a significant portion of new cancer diagnoses, with a subset presenting with tumor thrombus in the inferior vena cava (IVC), complicating treatment and ...